Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Jesús Duque‐Afonso|Blood Advances|2024Cited by 8
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic LeukemiaGila Mostufi-Zadeh-Haghighi, Jesús Duque‐Afonso|Cancers|2023Cited by 4